Tavros Therapeutics Achieves Two Milestone Payments in its Collaboration with Vividion Therapeutics [Yahoo! Finance]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Yahoo! Finance
DURHAM, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- Tavros Therapeutics, Inc., a precision oncology platform company, today announced that the Company has achieved two milestone payments in its collaboration with Vividion Therapeutics, Inc., a wholly owned and independently operated subsidiary of Bayer AG. The payments were triggered by the successful achievement of predefined milestones, underscoring the progress of their strategic collaboration to discover and develop targeted oncology therapies. Eoin McDonnell, Ph.D., CEO and co-founder of Tavros, remarked, “These milestones signify crucial advancements in our collaboration with Vividion. They highlight the strength of our precision oncology platform, EVOLVE™, and Vividion's commitment to exploring innovative treatment options across various tumor types to maximize patient benefit.” Under the terms of the five-year agreement, which began in October 2022, Tavros received $17.5 million in a cash upfront payment from Vividion and is e
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Founder of Hua Medicine Dr. Li CHEN was awarded the "C.C. Tan Life Science Industrialization Award" [Yahoo! Finance]Yahoo! Finance
- Expanding The Toolbox For Agricultural Pest Control [Forbes]Forbes
- Long Beach plans to host eight Olympic events, will spend $933 million on infrastructure [Los Angeles Times (CA)]Los Angeles Times
- AskBio Announces 11 Presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting 2024 [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Forward Global Expands with Launch of Dedicated Chemicals Practice, Simon Terwagne Appointed as Head [Yahoo! Finance]Yahoo! Finance